1R3.F IZOTROPIC CORP.

Healthcare Biotechnology Frankfurt Exchange
0.0670 EUR
Close of Nov 11, 2026
0.0360 0.2170
Market cap
EUR 4.85M
P/E
-
P/B
99.59x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.

Is 1R3.F undervalued?

Graham number

The Graham number of IZOTROPIC CORP. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

IZOTROPIC CORP. fundamental analysis

No fundamental analysis for IZOTROPIC CORP. yet.

IZOTROPIC CORP. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About IZOTROPIC CORP.

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a breast CT imaging system. The company was incorporated in 2016 and is headquartered in Surrey, Canada.

Full company profile